O08: Long-term efficacy and safety of pegzilarginase for arginase 1 deficiency: 2 years of experience in the phase 2 extension study*

• Markey McNutt,
• George Diaz,
• Andreas Schulze,
• Gillian Bubb,
• Leslie Sloan,
• Elisa Leão-Teles,
• Spyros Batzios,
• Angela Sun,
• Allison Bannick,
• Roberto Zori,
• Gregory Enns

Affiliations

Markey McNutt

UT Southwestern Medical Center

George Diaz

Icahn School of Medicine at Mount Sinai

Andreas Schulze

University of Toronto and The Hospital for Sick Children

Gillian Bubb

Aeglea BioTherapeutics, Inc.

Leslie Sloan

Aeglea BioTherapeutics, Inc.

Elisa Leão-Teles

Centro Hospitalar de São João

Spyros Batzios

Great Ormond Street Hospital NHS Trust

Angela Sun

University of Washington and Seattle Children's Hospital

Allison Bannick

Children's Hospital of Michigan, Wayne State University

Roberto Zori

University of Florida

Gregory Enns

Stanford University and Lucile Packard Children’s Hospital